FR2693907B1
(fr)
*
|
1992-07-23 |
1994-09-02 |
Rhone Poulenc Rorer Sa |
Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
WO1995010989A1
(en)
*
|
1993-10-19 |
1995-04-27 |
Scimed Life Systems, Inc. |
Intravascular stent pump
|
US5496360A
(en)
*
|
1994-04-12 |
1996-03-05 |
Ventritex, Inc. |
Implantable cardiac electrode with rate controlled drug delivery
|
DE69431533T2
(de)
*
|
1994-06-13 |
2003-10-02 |
Alza Corp., Palo Alto |
Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
|
US5633011A
(en)
*
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
US5718700A
(en)
*
|
1994-09-20 |
1998-02-17 |
Alza Corporation |
Exit means in dosage form
|
US5531734A
(en)
*
|
1995-01-13 |
1996-07-02 |
Abbott Laboratories |
Method of altering composition of nutritional product during enteral tube feeding
|
US5533973A
(en)
*
|
1995-01-13 |
1996-07-09 |
Abbott Laboratories |
Alteration of nutritional product during enteral tube feeding
|
US6036669A
(en)
|
1995-01-13 |
2000-03-14 |
Abbott Laboratories |
Apparatus for altering composition of nutritional product during enteral tube feeding
|
US5531682A
(en)
*
|
1995-01-13 |
1996-07-02 |
Abbott Laboratories |
Apparatus for adding marker dye to nutritional product during enternal tube feeding
|
US6277092B1
(en)
|
1995-01-13 |
2001-08-21 |
Abbott Laboratories |
Apparatus for altering composition of nutritional product during enteral tube feeding
|
US5531681A
(en)
*
|
1995-01-13 |
1996-07-02 |
Abbott Laboratories |
Apparatus for altering composition of nutritional product during enteral tube feeding
|
FR2731154B1
(fr)
*
|
1995-03-03 |
1997-05-09 |
Roussel Uclaf |
Compositions pharmaceutiques comprenant des derives de dinoreburnamenine
|
US5651979A
(en)
*
|
1995-03-30 |
1997-07-29 |
Gel Sciences, Inc. |
Apparatus and method for delivering a biologically active compound into a biological environment
|
US5800422A
(en)
*
|
1995-06-02 |
1998-09-01 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery and complete drug release
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6156331A
(en)
*
|
1996-02-02 |
2000-12-05 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
PT877599E
(pt)
*
|
1996-02-02 |
2003-08-29 |
Alza Corp |
Administracao continua de leuprolido utilizando um sistema implantavel
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
JP4215188B2
(ja)
*
|
1997-12-22 |
2009-01-28 |
インターシア セラピューティクス,インコーポレイティド |
薬剤供給を調節するデバイスのための速度調節膜
|
US6080132A
(en)
*
|
1998-02-27 |
2000-06-27 |
Abbott Laboratories |
Apparatus for altering characteristics of a fluid
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
JP2002514592A
(ja)
*
|
1998-05-14 |
2002-05-21 |
アルザ コーポレイション |
抗うつ剤療法
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
US6309373B1
(en)
|
1998-08-12 |
2001-10-30 |
Abbott Laboratories |
Apparatus for altering the characteristics of a fluid
|
US6183466B1
(en)
|
1998-08-21 |
2001-02-06 |
Alza Corporation |
Dosage form comprising a capsule
|
US6099862A
(en)
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
US6551613B1
(en)
*
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
DE69928815T2
(de)
*
|
1998-09-09 |
2006-06-29 |
Alza Corp., Mountain View |
Dosierungsform mit flüssiger formulierung
|
US6706282B1
(en)
*
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
GB9824658D0
(en)
*
|
1998-11-11 |
1999-01-06 |
Brown Malcolm D |
A capsule based drug delivery system
|
CA2354472C
(en)
*
|
1998-12-17 |
2009-02-24 |
Alza Corporation |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
WO2000037058A1
(en)
|
1998-12-18 |
2000-06-29 |
Alza Corporation |
Transparent transdermal nicotine delivery devices
|
US6198966B1
(en)
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
JP3061616B1
(ja)
*
|
1999-04-09 |
2000-07-10 |
株式会社セラリカ野田 |
低カロリ―調製ロ―ヤルゼリ―
|
DE19923817A1
(de)
*
|
1999-05-18 |
2000-11-23 |
Roland Bodmeier |
Kapsel mit kontrollierter Wirkstofffreisetzung
|
US20060015075A1
(en)
*
|
1999-06-22 |
2006-01-19 |
Erblan Surgical Inc. |
Guarded infusor needle and infusor locking system
|
US20040230155A1
(en)
*
|
1999-06-22 |
2004-11-18 |
Erblan Surgical Inc. |
Insufflator and method of use
|
US6251432B1
(en)
|
1999-07-01 |
2001-06-26 |
Abbott Laboratories |
Sustained release dosage form unit having latex coating and method of making the same
|
WO2001041742A2
(en)
*
|
1999-12-09 |
2001-06-14 |
Alza Corporation |
Antiviral medication
|
AR026148A1
(es)
*
|
2000-01-21 |
2003-01-29 |
Osmotica Argentina S A |
Dispositivo osmotico con pasaje preformado que aumenta de tamano
|
ES2233611T3
(es)
|
2000-02-04 |
2005-06-16 |
Alza Corporation |
Dispensador de fluidos de accionamiento osmotico.
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
GB2398499B
(en)
*
|
2000-02-16 |
2004-11-24 |
Bioprogress Technology Ltd |
Two layer capsules
|
GB0003424D0
(en)
*
|
2000-02-16 |
2000-04-05 |
Bioprogress Tech Int Inc |
A controlled release capsule
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US6468559B1
(en)
*
|
2000-04-28 |
2002-10-22 |
Lipocine, Inc. |
Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods
|
US20040230160A1
(en)
*
|
2000-06-22 |
2004-11-18 |
Erblan Surgical Inc. |
Safety trocar including sealing member
|
US20020161387A1
(en)
*
|
2000-06-22 |
2002-10-31 |
Blanco Ernesto E. |
Safety trocar with progressive cutting tip guards and gas jet tissue deflector
|
WO2002054996A2
(en)
*
|
2000-10-23 |
2002-07-18 |
Euro Celtique Sa |
Terazosin transdermal device and methods
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
KR20040007413A
(ko)
*
|
2000-11-03 |
2004-01-24 |
바이오메디신즈 인코포레이티드 |
단기 및 장기 약물 약량측정 방법
|
DE10100689A1
(de)
*
|
2001-01-09 |
2002-07-18 |
Henkel Kgaa |
Wasch- und reinigungsaktive Substanzen enthaltende Mikrokapseln
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
EP1404297B1
(en)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
US7163688B2
(en)
*
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
EP1578246B1
(en)
*
|
2001-07-12 |
2014-09-03 |
Given Imaging Ltd. |
Device for examining a body lumen
|
US7349733B2
(en)
*
|
2001-11-02 |
2008-03-25 |
Ceramatel, Inc. |
Iontophoretic drug delivery systems
|
CN100438870C
(zh)
*
|
2001-11-09 |
2008-12-03 |
精达制药公司 |
ω干扰素在制备治疗温血动物对象中病毒性疾病的药物中的用途
|
US20030232078A1
(en)
*
|
2001-12-19 |
2003-12-18 |
Dong Liang C. |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
MXPA04006026A
(es)
*
|
2001-12-19 |
2005-03-31 |
Alza Corp |
Formulacion y forma de dosificacion para aumentar la biodisponibilidad oral de macromoleculas hidrofilitas.
|
US7047069B2
(en)
|
2002-02-04 |
2006-05-16 |
Ceramatec, Inc. |
Iontophoretic fluid delivery device
|
US6775570B2
(en)
|
2002-02-04 |
2004-08-10 |
Ceramatec, Inc. |
Iontophoretic treatment device
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
WO2003099214A2
(en)
*
|
2002-05-23 |
2003-12-04 |
Andrx Corporation |
Biguanide formulations
|
CA2489325C
(en)
*
|
2002-06-17 |
2010-08-10 |
Alza Corporation |
Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
|
KR101046903B1
(ko)
*
|
2002-06-26 |
2011-07-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
삼투성 약물 전달 시스템을 위한, 최소로 튀는 용적효율성 피스톤
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20050175697A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Novel drug compositions and dosage forms of topiramate
|
US20040115262A1
(en)
*
|
2002-07-29 |
2004-06-17 |
Frank Jao |
Formulations and dosage forms for controlled delivery of topiramate
|
TW200414900A
(es)
*
|
2002-06-28 |
2004-08-16 |
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
US20040142040A1
(en)
*
|
2002-10-31 |
2004-07-22 |
Dong Liang C. |
Formulation and dosage form providing increased bioavailability of hydrophobic drugs
|
EP1556017A1
(en)
*
|
2002-10-31 |
2005-07-27 |
ALZA Corporation |
Dosage form providing ascending release of liquid formulation
|
US7014636B2
(en)
*
|
2002-11-21 |
2006-03-21 |
Alza Corporation |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
|
US7491234B2
(en)
*
|
2002-12-03 |
2009-02-17 |
Boston Scientific Scimed, Inc. |
Medical devices for delivery of therapeutic agents
|
BR0317275A
(pt)
*
|
2002-12-11 |
2005-11-08 |
Pfizer Prod Inc |
Liberação controlada de uma substância ativa em um ambiente de gordura alta
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
TWI367103B
(en)
|
2003-06-26 |
2012-07-01 |
Psivida Inc |
Bioerodible sustained release drug delivery systems
|
DE602004016995D1
(de)
*
|
2003-06-26 |
2008-11-20 |
Control Delivery Sys Inc |
In-situ gelierendes arzneimittelabgabesystem
|
CN1842321B
(zh)
*
|
2003-06-26 |
2012-07-04 |
控制递送系统有限公司 |
生物蚀解性缓释递药系统
|
EP1653922A2
(en)
*
|
2003-08-06 |
2006-05-10 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
AU2004268549A1
(en)
*
|
2003-08-22 |
2005-03-10 |
Alza Corporation |
Stepwise delivery of topiramate over prolonged period of time
|
EP1701697A2
(en)
*
|
2003-09-02 |
2006-09-20 |
ALZA Corporation |
Novel drug compositions and dosage forms of topiramate
|
EP1684713A1
(en)
*
|
2003-11-14 |
2006-08-02 |
ALZA Corporation |
Controlled release of topirimate in liquid dosage forms
|
AU2004308973A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
JP2007517061A
(ja)
*
|
2003-12-29 |
2007-06-28 |
アルザ・コーポレーシヨン |
新規薬剤組成物及び投与形態物
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
US7943294B2
(en)
*
|
2004-07-30 |
2011-05-17 |
Hologic, Inc. |
Methods for detecting oncofetal fibronectin
|
US20060045891A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Lovalenti Phillip M |
Density-matched suspension vehicles and pharmaceutical suspensions
|
CA2596029A1
(en)
*
|
2005-01-27 |
2006-08-03 |
David E. Edgren |
Oral osmotic dosage form having a high flux membrane
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
CN101232868A
(zh)
*
|
2005-04-19 |
2008-07-30 |
阿尔扎公司 |
曲马多和加巴喷丁的控释递药剂型
|
JP2008542308A
(ja)
*
|
2005-06-02 |
2008-11-27 |
タリオン ファーマシューティカルズ インク. |
ファルネシルジベンゾジアゼピノン製剤
|
US20090214643A1
(en)
*
|
2005-07-19 |
2009-08-27 |
Franklin Amie E |
Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
|
AR055099A1
(es)
*
|
2005-07-28 |
2007-08-08 |
Alza Corp |
Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
AU2007284759B2
(en)
|
2006-08-09 |
2010-10-28 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
US20080177219A1
(en)
*
|
2007-01-23 |
2008-07-24 |
Joshi Ashok V |
Method for Iontophoretic Fluid Delivery
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
GB0707127D0
(en)
*
|
2007-04-13 |
2007-05-23 |
Zysis Ltd |
Pharmaceutical compositions
|
RU2440097C2
(ru)
|
2007-04-23 |
2012-01-20 |
Интарсия Терапьютикс, Инк. |
Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
|
US8197844B2
(en)
|
2007-06-08 |
2012-06-12 |
Activatek, Inc. |
Active electrode for transdermal medicament administration
|
US20090087484A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
US20090110724A1
(en)
*
|
2007-10-31 |
2009-04-30 |
Everett Laboratories, Inc. |
Compositions and methods for treatment of pain
|
US8862223B2
(en)
|
2008-01-18 |
2014-10-14 |
Activatek, Inc. |
Active transdermal medicament patch and circuit board for same
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
US20090312627A1
(en)
*
|
2008-06-16 |
2009-12-17 |
Matott Laura A |
Radio-labeled ingestible capsule
|
CA2638240C
(en)
*
|
2008-08-29 |
2010-02-02 |
Alexander Macgregor |
Method of treating dysglycemia and glucose excursions
|
PL2391419T3
(pl)
|
2009-01-29 |
2019-12-31 |
Forsight Vision4, Inc. |
Dostarczanie leku do tylnego odcinka
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
CA2757979A1
(en)
*
|
2009-04-09 |
2010-10-14 |
Alkermes Pharma Ireland Limited |
Controlled-release clozapine compositions
|
CA2979355C
(en)
*
|
2009-05-18 |
2023-02-21 |
Dose Medical Corporation |
Drug eluting ocular implant
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
DK2442791T3
(da)
|
2009-06-16 |
2020-03-02 |
Pfizer |
Former til dosering af apixaban
|
WO2011006066A1
(en)
|
2009-07-10 |
2011-01-13 |
Ironwood Pharmaceuticals, Inc. |
Cb receptor agonists
|
WO2011032386A1
(zh)
*
|
2009-09-15 |
2011-03-24 |
北京天衡药物研究院 |
一种渗透泵型控释片及其制备方法
|
EP3735944A1
(en)
|
2009-09-28 |
2020-11-11 |
Intarcia Therapeutics, Inc. |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
EP2516416A1
(en)
|
2009-12-23 |
2012-10-31 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
EP2515864A4
(en)
*
|
2009-12-23 |
2013-09-11 |
Psivida Inc |
DELAYED RELEASE DELIVERY DEVICES
|
US8945010B2
(en)
|
2009-12-23 |
2015-02-03 |
Covidien Lp |
Method of evaluating constipation using an ingestible capsule
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
WO2011100359A1
(en)
|
2010-02-09 |
2011-08-18 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid agonists
|
US20130196960A1
(en)
|
2010-02-09 |
2013-08-01 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid Receptor Agonists
|
US20130178475A1
(en)
|
2010-03-17 |
2013-07-11 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
AR088020A1
(es)
|
2010-06-30 |
2014-05-07 |
Ironwood Pharmaceuticals Inc |
Compuestos heterociclicos como estimuladores de sgc
|
US20130259830A1
(en)
|
2010-07-12 |
2013-10-03 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
US20130216552A1
(en)
|
2010-07-12 |
2013-08-22 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
WO2012019136A2
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision 4, Inc. |
Injector apparatus and method for drug delivery
|
SI2600812T1
(sl)
|
2010-08-05 |
2021-12-31 |
ForSight Vision4, Inc., |
Naprava za zdravljenje očesa
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
NZ607554A
(en)
|
2010-08-30 |
2015-04-24 |
Sinusys Corp |
Devices for dilating a paranasal sinus opening and for treating sinusitis
|
CA2817319A1
(en)
|
2010-11-09 |
2012-05-18 |
Ironwood Pharmaceuticals, Inc. |
Triazole derivatives as sgc stimulators
|
US20140031769A1
(en)
|
2010-11-19 |
2014-01-30 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
RS61758B1
(sr)
|
2011-09-16 |
2021-05-31 |
Forsight Vision4 Inc |
Aparati za razmenu tečnosti
|
CN104066731B
(zh)
|
2011-12-27 |
2016-06-15 |
铁木医药有限公司 |
可用作sgc刺激剂的2-苄基、3-(嘧啶-2-基)取代的吡唑类
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
EP2819740A4
(en)
|
2012-02-29 |
2015-11-25 |
Sinusys Corp |
DEVICES AND METHOD FOR DILATING A PARANASAL SINUS OPENING AND FOR TREATING SINUSITIS
|
US20150080381A1
(en)
|
2012-04-12 |
2015-03-19 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating alopecia and acne
|
US9309235B2
(en)
|
2012-09-18 |
2016-04-12 |
Ironwood Pharmaceuticals, Inc. |
SGC stimulators
|
CA2885645A1
(en)
|
2012-09-19 |
2014-03-27 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
CA2905496A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
KR102362835B1
(ko)
|
2013-03-15 |
2022-02-14 |
사이클리온 테라퓨틱스, 인크. |
sGC 자극인자
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
US9687263B2
(en)
|
2013-05-30 |
2017-06-27 |
SinuSys Corporation |
Devices and methods for inserting a sinus dilator
|
KR102488491B1
(ko)
*
|
2013-08-19 |
2023-01-12 |
타리스 바이오메디컬 엘엘씨 |
다중 유닛 약물 전달 장치 및 방법
|
US20160310408A1
(en)
*
|
2013-12-06 |
2016-10-27 |
Durect Corporation |
Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
|
CA2933250A1
(en)
|
2013-12-11 |
2015-06-18 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
EP3148491B1
(en)
|
2014-05-29 |
2020-07-01 |
Glaukos Corporation |
Implants with controlled drug delivery features and manufacturing method for said implants
|
RU2695563C2
(ru)
|
2014-07-15 |
2019-07-24 |
Форсайт Вижн4, Инк. |
Способ и устройство для доставки глазного имплантата
|
CN107106551A
(zh)
|
2014-08-08 |
2017-08-29 |
弗赛特影像4股份有限公司 |
受体酪氨酸激酶抑制剂的稳定且可溶的制剂和其制备方法
|
US20170298055A1
(en)
|
2014-09-17 |
2017-10-19 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
JP2017527604A
(ja)
|
2014-09-17 |
2017-09-21 |
アイアンウッド ファーマシューティカルズ インコーポレイテッド |
sGC刺激剤
|
MX2017003516A
(es)
|
2014-09-17 |
2017-07-28 |
Ironwood Pharmaceuticals Inc |
Derivados de pirazol como estimuladores de guanilato ciclasa soluble (sgc).
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
RU2708958C2
(ru)
|
2014-11-10 |
2019-12-12 |
Форсайт Вижн4, Инк. |
Расширяемые устройства доставки лекарственных средств и способы использования
|
MA44390A
(fr)
|
2015-06-03 |
2019-01-23 |
Intarcia Therapeutics Inc |
Systèmes de mise en place et de retrait d'implant
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
MX2018006234A
(es)
|
2015-11-20 |
2018-08-14 |
Forsight Vision4 Inc |
Estructuras porosas para dispositivos de suministro de medicamentos de liberacion prolongada.
|
MX2018012021A
(es)
|
2016-04-05 |
2019-01-24 |
Forsight Vision4 Inc |
Dispositivos de administracion de farmacos oculares implantables.
|
EP3442479A1
(en)
|
2016-04-20 |
2019-02-20 |
Harold Alexander Heitzmann |
Bioresorbable ocular drug delivery device
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
IL292968A
(en)
|
2016-09-02 |
2022-07-01 |
Cyclerion Therapeutics Inc |
scg motors in converging cycles
|
EP3538096B1
(en)
|
2016-11-08 |
2024-02-28 |
Tisento Therapeutics Inc. |
Treatment of cns diseases with sgc stimulators
|
CA3042713A1
(en)
|
2016-11-08 |
2018-05-17 |
Cyclerion Therapeutics, Inc. |
Sgc stimulators
|
IL267736B2
(en)
|
2017-01-03 |
2024-03-01 |
Intarcia Therapeutics Inc |
Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
WO2019103906A1
(en)
|
2017-11-21 |
2019-05-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|